ERIC SCHLUEDERBERG: Open Payments
NPI 1871856583 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$252 in 8 payments from 5 companies in 2025. Trend: 2023 $674 · 2024 $138 · 2025 $252
Food & beverage: $252
| Company | Payments | Amount |
|---|---|---|
| RedHill Biopharma Inc. | 3 | $108 |
| Gilead Sciences, Inc. | 2 | $63 |
| ViiV Healthcare Company | 1 | $34 |
| Lilly USA, LLC | 1 | $24 |
| Novo Nordisk Inc | 1 | $23 |
Products named: Talicia, APRETUDE, Ozempic.
Industry payments across CA — which companies pay providers there.
